Cargando…

Wnt1 Promotes EAAT2 Expression and Mediates the Protective Effects of Astrocytes on Dopaminergic Cells in Parkinson's Disease

BACKGROUND: Wnt/β-catenin signaling has been reported to exert cytoprotective effects in a cellular model of Parkinson's disease (PD). Glutamate excitotoxicity has been suggested to contribute to the pathogenesis of PD, and excitatory amino acid transporters (EAATs) play a predominant role in c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Lei, Chen, Chuan, Ding, Li, Mo, Mingshu, Zou, Jing, Lu, Zhenze, Li, Haiyan, Wu, Haotian, Dai, Yongqiang, Xu, Pingyi, Lu, Zhengqi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6754970/ https://www.ncbi.nlm.nih.gov/pubmed/31582965 http://dx.doi.org/10.1155/2019/1247276

Ejemplares similares

Astrocytic transcription factor REST upregulates glutamate transporter EAAT2, protecting dopaminergic neurons from manganese-induced excitotoxicity
por: Pajarillo, Edward, et al.
Publicado: (2021)

Xiaoyaosan exerts antidepressant-like effects by regulating the functions of astrocytes and EAATs in the prefrontal cortex of mice
por: Liu, Yan, et al.
Publicado: (2019)

Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
por: Almilaji, Ahmad, et al.
Publicado: (2013)

Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings
por: Dalet, Antoine, et al.
Publicado: (2012)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

A Computational Study of Astrocytic GABA Release at the Glutamatergic Synapse: EAAT-2 and GAT-3 Coupled Dynamics
por: Flanagan, Bronac, et al.
Publicado: (2021)

Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
por: Tang, Yuting, et al.
Publicado: (2023)

Astrocytes protect dopaminergic neurons against aminochrome neurotoxicity
por: Segura-Aguilar, Juan, et al.
Publicado: (2022)

Glutamate Transporters EAAT2 and EAAT5 Differentially Shape Synaptic Transmission from Rod Bipolar Cell Terminals
por: Tang, Fu-Sheng, et al.
Publicado: (2022)

Striatal astrocytes engulf dopaminergic debris in Parkinson's disease: A study in an animal model
por: Morales, Ingrid, et al.
Publicado: (2017)

Astrocytes and retrograde degeneration of nigrostriatal dopaminergic neurons in Parkinson’s disease: removing axonal debris
por: Morales, Ingrid, et al.
Publicado: (2021)

Cellular Physiology and Pathophysiology of EAAT Anion Channels
por: Kovermann, Peter, et al.
Publicado: (2022)

Calcineurin Controls Expression of EAAT1/GLAST in Mouse and Human Cultured Astrocytes through Dynamic Regulation of Protein Synthesis and Degradation
por: Dematteis, Giulia, et al.
Publicado: (2020)

A new mechanism for protection of dopaminergic neurons mediated by astrocytes
por: Segura-Aguilar, Juan
Publicado: (2015)

The biomarkers of immune dysregulation and inflammation response in Parkinson disease
por: Chen, Li, et al.
Publicado: (2016)

CHCHD2 maintains mitochondrial contact site and cristae organizing system stability and protects against mitochondrial dysfunction in an experimental model of Parkinson's disease
por: Lu, Lin, et al.
Publicado: (2022)

Raloxifene Suppresses Experimental Autoimmune Encephalomyelitis and NF-κB-Dependent CCL20 Expression in Reactive Astrocytes
por: Li, Rui, et al.
Publicado: (2014)

WNT signaling in midbrain dopaminergic neuron development and cell replacement therapies for Parkinson’s disease
por: Arenas, Ernest, et al.
Publicado: (2015)

Bone-Derived Factors as Potential Biomarkers for Parkinson’s Disease
por: Lin, Yuwan, et al.
Publicado: (2021)

Astrocytic JWA deletion exacerbates dopaminergic neurodegeneration by decreasing glutamate transporters in mice
por: Wang, Rihua, et al.
Publicado: (2018)

Structural basis of ligand binding modes of human EAAT2
por: Zhang, Zhenglai, et al.
Publicado: (2022)

Mirtazapine exerts astrocyte-mediated dopaminergic neuroprotection
por: Kikuoka, Ryo, et al.
Publicado: (2020)

Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function
por: Wei, Lei, et al.
Publicado: (2015)

Depletion of canonical Wnt signaling components has a neuroprotective effect on midbrain dopaminergic neurons in an MPTP-induced mouse model of Parkinson’s disease
por: DAI, TING-LI, et al.
Publicado: (2014)

Molecular Dynamics Simulations of the Mammalian Glutamate Transporter EAAT3
por: Heinzelmann, Germano, et al.
Publicado: (2014)

Excitatory Amino Acid Transporters (EAATs): Glutamate Transport and Beyond
por: Magi, Simona, et al.
Publicado: (2019)

The Neuronal Glutamate Transporter EAAT3 in Obsessive-Compulsive Disorder
por: Escobar, Angélica P., et al.
Publicado: (2019)

Effects of tranexamic acid on the activity of glutamate transporter EAAT3
por: Shin, Hyun-Jung, et al.
Publicado: (2020)

EAAT5 Glutamate Transporter-Mediated Inhibition in the Vertebrate Retina
por: Lukasiewcz, Peter D., et al.
Publicado: (2021)

The Glutamate Transporter Subtypes EAAT4 and EAATs 1-3 Transport Glutamate with Dramatically Different Kinetics and Voltage Dependence but Share a Common Uptake Mechanism
por: Mim, Carsten, et al.
Publicado: (2005)

Astrocytic Expression of GSTA4 Is Associated to Dopaminergic Neuroprotection in a Rat 6-OHDA Model of Parkinson’s Disease
por: Jewett, Michael, et al.
Publicado: (2017)

Repressing PTBP1 fails to convert reactive astrocytes to dopaminergic neurons in a 6-hydroxydopamine mouse model of Parkinson’s disease
por: Chen, Weizhao, et al.
Publicado: (2022)

Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease
por: Zhang, Yunlong, et al.
Publicado: (2017)

Moxibustion Protects Dopaminergic Neurons in Parkinson's Disease through Antiferroptosis
por: Huang, Zifeng, et al.
Publicado: (2021)

Roles Of EAAT1, DHFR, And Fetuin-A In The Pathogenesis, Progression And Prognosis Of Chondrosarcoma
por: He, Lile, et al.
Publicado: (2019)

Purkinje cell dopaminergic inputs to astrocytes regulate cerebellar-dependent behavior
por: Li, Chang, et al.
Publicado: (2023)

Gateways for Glutamate Neuroprotection in Parkinson’s Disease (PD): Essential Role of EAAT3 and NCX1 Revealed in an In Vitro Model of PD
por: Piccirillo, Silvia, et al.
Publicado: (2020)

Parkinson's disease and dopaminergic neurons
Publicado: (2012)

CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes
por: Zhang, Wenlong, et al.
Publicado: (2020)

Src Inhibition Attenuates Neuroinflammation and Protects Dopaminergic Neurons in Parkinson’s Disease Models
por: Yang, Hanyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_41ktmh46l6tddpl88mbj8hnhrm